Cervical cancer is the third most common cancer in women worldwide, with over 450,000 new cases and 230,000 deaths each year. Nearly all cervical cancer cases are caused by infection with human papillomavirus (HPV). Screening can detect precancerous lesions before they develop into invasive cancer. Visual inspection with acetic acid (VIA) is effective for cervical cancer screening, especially in low-resource settings, as it is inexpensive, non-invasive, and provides immediate results to inform treatment decisions. Integrating cervical cancer screening and treatment with other reproductive health services improves access to care.